BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28571770)

  • 1. Leptin induces CREB-dependent aromatase activation through COX-2 expression in breast cancer cells.
    Kim HG; Jin SW; Kim YA; Khanal T; Lee GH; Kim SJ; Rhee SD; Chung YC; Hwang YJ; Jeong TC; Jeong HG
    Food Chem Toxicol; 2017 Aug; 106(Pt A):232-241. PubMed ID: 28571770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cyclooxygenase-2-dependent signaling via cyclic AMP response element activation on aromatase up-regulation by o,p'-DDT in human breast cancer cells.
    Han EH; Kim HG; Hwang YP; Choi JH; Im JH; Park B; Yang JH; Jeong TC; Jeong HG
    Toxicol Lett; 2010 Oct; 198(3):331-41. PubMed ID: 20678559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
    Prosperi JR; Robertson FM
    Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphenol A-induced aromatase activation is mediated by cyclooxygenase-2 up-regulation in rat testicular Leydig cells.
    Kim JY; Han EH; Kim HG; Oh KN; Kim SK; Lee KY; Jeong HG
    Toxicol Lett; 2010 Mar; 193(2):200-8. PubMed ID: 20096755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 mRNA expression correlates with aromatase expression in human breast cancer.
    Salhab M; Singh-Ranger G; Mokbel R; Jouhra F; Jiang WG; Mokbel K
    J Surg Oncol; 2007 Oct; 96(5):424-8. PubMed ID: 17657731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase and COX in breast cancer: enzyme inhibitors and beyond.
    Brueggemeier RW; Su B; Sugimoto Y; Díaz-Cruz ES; Davis DD
    J Steroid Biochem Mol Biol; 2007; 106(1-5):16-23. PubMed ID: 17616393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase induction in tamoxifen-resistant breast cancer: Role of phosphoinositide 3-kinase-dependent CREB activation.
    Phuong NT; Lim SC; Kim YM; Kang KW
    Cancer Lett; 2014 Aug; 351(1):91-9. PubMed ID: 24836190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production.
    Bowers LW; Brenner AJ; Hursting SD; Tekmal RR; deGraffenried LA
    Breast Cancer Res Treat; 2015 Jan; 149(1):49-57. PubMed ID: 25476497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells.
    Naviglio S; Di Gesto D; Illiano F; Chiosi E; Giordano A; Illiano G; Spina A
    J Cell Physiol; 2010 Nov; 225(3):801-9. PubMed ID: 20589829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CRE-binding protein (CREB) in aromatase expression in breast adipose.
    Sofi M; Young MJ; Papamakarios T; Simpson ER; Clyne CD
    Breast Cancer Res Treat; 2003 Jun; 79(3):399-407. PubMed ID: 12846424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase.
    Takeda S; Yamamoto I; Watanabe K
    Toxicology; 2009 May; 259(1-2):25-32. PubMed ID: 19428940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclooxygenase-2 down-regulates aromatase activity and decreases proliferation of Leydig tumor cells.
    Sirianni R; Chimento A; De Luca A; Zolea F; Carpino A; Rago V; Maggiolini M; Andò S; Pezzi V
    J Biol Chem; 2009 Oct; 284(42):28905-16. PubMed ID: 19679653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of cyclooxygenase-2 by 4-nonylphenol is mediated through the cyclic amp response element activation pathway.
    Han EH; Hwang YP; Kim HG; Park JH; Jeong TC; Jeong HG
    J Toxicol Environ Health A; 2010; 73(21-22):1451-64. PubMed ID: 20954072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
    Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
    J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid estrogen effects on aromatase phosphorylation in breast cancer cells.
    Catalano S; Barone I; Andò S
    Methods Mol Biol; 2014; 1204():155-63. PubMed ID: 25182769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women.
    Subbaramaiah K; Morris PG; Zhou XK; Morrow M; Du B; Giri D; Kopelovich L; Hudis CA; Dannenberg AJ
    Cancer Discov; 2012 Apr; 2(4):356-65. PubMed ID: 22576212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women.
    Brown KA; McInnes KJ; Hunger NI; Oakhill JS; Steinberg GR; Simpson ER
    Cancer Res; 2009 Jul; 69(13):5392-9. PubMed ID: 19509226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer.
    Wang X; Docanto MM; Sasano H; ; Lo C; Simpson ER; Brown KA
    Cancer Res; 2015 Feb; 75(4):645-55. PubMed ID: 25634217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 drives cyclooxygenase-2 expression via cyclic AMP response element activation in human pancreatic cancer cells.
    Pino MS; Nawrocki ST; Cognetti F; Abruzzese JL; Xiong HQ; McConkey DJ
    Cancer Biol Ther; 2005 Nov; 4(11):1263-9. PubMed ID: 16319525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 activates cAMP response element-binding protein in glioma cells via a signaling pathway involving PKA-dependent inhibition of ERK.
    Bidwell P; Joh K; Leaver HA; Rizzo MT
    Prostaglandins Other Lipid Mediat; 2010 Feb; 91(1-2):18-29. PubMed ID: 20015475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.